251 related articles for article (PubMed ID: 25600372)
1. GABAA receptor partial agonists and antagonists: structure, binding mode, and pharmacology.
Krall J; Balle T; Krogsgaard-Larsen N; Sørensen TE; Krogsgaard-Larsen P; Kristiansen U; Frølund B
Adv Pharmacol; 2015; 72():201-27. PubMed ID: 25600372
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of extra-synaptic α5-GABA
Etherington LA; Mihalik B; Pálvölgyi A; Ling I; Pallagi K; Kertész S; Varga P; Gunn BG; Brown AR; Livesey MR; Monteiro O; Belelli D; Barkóczy J; Spedding M; Gacsályi I; Antoni FA; Lambert JJ
Neuropharmacology; 2017 Oct; 125():353-364. PubMed ID: 28807671
[TBL] [Abstract][Full Text] [Related]
3. The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors.
Hoestgaard-Jensen K; O'Connor RM; Dalby NO; Simonsen C; Finger BC; Golubeva A; Hammer H; Bergmann ML; Kristiansen U; Krogsgaard-Larsen P; Bräuner-Osborne H; Ebert B; Frølund B; Cryan JF; Jensen AA
Br J Pharmacol; 2013 Oct; 170(4):919-32. PubMed ID: 23957253
[TBL] [Abstract][Full Text] [Related]
4. Subtype Selective γ-Aminobutyric Acid Type A Receptor (GABA
Maramai S; Benchekroun M; Ward SE; Atack JR
J Med Chem; 2020 Apr; 63(7):3425-3446. PubMed ID: 31738537
[TBL] [Abstract][Full Text] [Related]
5. GABA
Olsen RW
Neuropharmacology; 2018 Jul; 136(Pt A):10-22. PubMed ID: 29407219
[TBL] [Abstract][Full Text] [Related]
6. Probing α4βδ GABAA receptor heterogeneity: differential regional effects of a functionally selective α4β1δ/α4β3δ receptor agonist on tonic and phasic inhibition in rat brain.
Hoestgaard-Jensen K; Dalby NO; Krall J; Hammer H; Krogsgaard-Larsen P; Frølund B; Jensen AA
J Neurosci; 2014 Dec; 34(49):16256-72. PubMed ID: 25471566
[TBL] [Abstract][Full Text] [Related]
7. Probing the orthosteric binding site of GABAA receptors with heterocyclic GABA carboxylic acid bioisosteres.
Petersen JG; Bergmann R; Krogsgaard-Larsen P; Balle T; Frølund B
Neurochem Res; 2014 Jun; 39(6):1005-15. PubMed ID: 24362592
[TBL] [Abstract][Full Text] [Related]
8. Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABA
Olander ER; Madjroh N; Bunch L; Söderhielm PC; Jensen AA
Biochem Pharmacol; 2018 Apr; 150():305-319. PubMed ID: 29454619
[TBL] [Abstract][Full Text] [Related]
9. Orthosteric and benzodiazepine cavities of the α
Amundarain MJ; Viso JF; Zamarreño F; Giorgetti A; Costabel M
J Biomol Struct Dyn; 2019 Apr; 37(6):1597-1615. PubMed ID: 29633901
[TBL] [Abstract][Full Text] [Related]
10. The Influence of AA29504 on GABA
Sikstus S; Benkherouf AY; Soini SL; Uusi-Oukari M
Neurochem Res; 2022 Mar; 47(3):667-678. PubMed ID: 34727270
[TBL] [Abstract][Full Text] [Related]
11. Insights into the structure and pharmacology of GABA(A) receptors.
Carter CR; Kozuska JL; Dunn SM
Future Med Chem; 2010 May; 2(5):859-75. PubMed ID: 21426206
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of New GABA
Guerrini G; Vergelli C; Cantini N; Giovannoni MP; Daniele S; Mascia MP; Martini C; Crocetti L
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901916
[TBL] [Abstract][Full Text] [Related]
13. 5-(Piperidin-4-yl)-3-hydroxypyrazole: A novel scaffold for probing the orthosteric γ-aminobutyric acid type A receptor binding site.
Krall J; Kongstad KT; Nielsen B; Sørensen TE; Balle T; Jensen AA; Frølund B
ChemMedChem; 2014 Nov; 9(11):2475-85. PubMed ID: 25156407
[TBL] [Abstract][Full Text] [Related]
14. Allosteric modulation of GABAA receptors via multiple drug-binding sites.
Sieghart W
Adv Pharmacol; 2015; 72():53-96. PubMed ID: 25600367
[TBL] [Abstract][Full Text] [Related]
15. Extrasynaptic α6 subunit-containing GABAA receptors modulate excitability in turtle spinal motoneurons.
Andres C; Aguilar J; González-Ramírez R; Elias-Viñas D; Felix R; Delgado-Lezama R
PLoS One; 2014; 9(12):e115378. PubMed ID: 25531288
[TBL] [Abstract][Full Text] [Related]
16. An Emerging Circuit Pharmacology of GABA
Engin E; Benham RS; Rudolph U
Trends Pharmacol Sci; 2018 Aug; 39(8):710-732. PubMed ID: 29903580
[TBL] [Abstract][Full Text] [Related]
17. Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Top Med Chem; 2012; 12(4):286-311. PubMed ID: 22204484
[TBL] [Abstract][Full Text] [Related]
18. Determining the relative efficacy of positive allosteric modulators of the GABAA receptor: design of a screening approach.
Ghisdal P; Noel N; Pacico N; Martini M; Foerch P; Hanon E; Wolff C
J Biomol Screen; 2014 Mar; 19(3):462-7. PubMed ID: 23989455
[TBL] [Abstract][Full Text] [Related]
19. Peripheral GABA
Lee PR; Yoon SY; Kim HW; Yeo JH; Kim YH; Oh SB
Neuropharmacology; 2018 Jun; 135():572-580. PubMed ID: 29634983
[TBL] [Abstract][Full Text] [Related]
20. Optopharmacology reveals a differential contribution of native GABA
Mortensen M; Huckvale R; Pandurangan AP; Baker JR; Smart TG
Neuropharmacology; 2020 Oct; 176():108135. PubMed ID: 32445639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
